Azure Healthcare Limited, together with its subsidiaries, manufactures, services, supplies, and distributes healthcare and electronic communications equipment in Australia, New Zealand, Asia, Europe, and North America.
Flawless balance sheet and undervalued.
Share Price & News
How has Azure Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AZV's share price has been volatile over the past 3 months.
7 Day Return
AU Medical Equipment
1 Year Return
AU Medical Equipment
Return vs Industry: AZV underperformed the Australian Medical Equipment industry which returned -1.7% over the past year.
Return vs Market: AZV exceeded the Australian Market which returned -22.8% over the past year.
Price Volatility Vs. Market
How volatile is Azure Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StCan Azure Healthcare Limited (ASX:AZV) Maintain Its Strong Returns?
3 weeks ago | Simply Wall StShareholders Should Look Hard At Azure Healthcare Limited’s (ASX:AZV) 0.3%Return On Capital
1 month ago | Simply Wall StShould You Be Pleased About The CEO Pay At Azure Healthcare Limited's (ASX:AZV)
Is Azure Healthcare undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AZV (A$0.06) is trading below our estimate of fair value (A$0.13)
Significantly Below Fair Value: AZV is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AZV is good value based on its PE Ratio (6.8x) compared to the Medical Equipment industry average (15.7x).
PE vs Market: AZV is good value based on its PE Ratio (6.8x) compared to the Australian market (12.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AZV's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AZV is good value based on its PB Ratio (1.1x) compared to the AU Medical Equipment industry average (3.2x).
How is Azure Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Azure Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether Azure Healthcare is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Azure Healthcare competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Azure Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AZV has high quality earnings.
Growing Profit Margin: AZV's current net profit margins (5.7%) are higher than last year (1%).
Past Earnings Growth Analysis
Earnings Trend: AZV has become profitable over the past 5 years, growing earnings by 19.9% per year.
Accelerating Growth: AZV's earnings growth over the past year (554.5%) exceeds its 5-year average (19.9% per year).
Earnings vs Industry: AZV earnings growth over the past year (554.5%) exceeded the Medical Equipment industry 14.7%.
Return on Equity
High ROE: AZV's Return on Equity (13.2%) is considered low.
How is Azure Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: AZV's short term assets (A$18.7M) exceed its short term liabilities (A$8.0M).
Long Term Liabilities: AZV's short term assets (A$18.7M) exceed its long term liabilities (A$708.0K).
Debt to Equity History and Analysis
Debt Level: AZV's debt to equity ratio (0.4%) is considered satisfactory.
Reducing Debt: AZV's debt to equity ratio has reduced from 8.3% to 0.4% over the past 5 years.
Inventory Level: AZV has a high level of physical assets or inventory.
Debt Coverage by Assets: AZV's debt is covered by short term assets (assets are 323.2x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AZV is profitable, therefore cash runway is not a concern.
Forecast Cash Runway: AZV is profitable, therefore cash runway is not a concern.
What is Azure Healthcare's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AZV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate AZV's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AZV's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AZV's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: AZV is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AZV's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Clayton Astles has been the Chief Executive Officer of Azure Healthcare Limited since July 31, 2015. Mr. Astles serves as the President of Azure Healthcare's main operating subsidiary Austco. He has he ...
CEO Compensation Analysis
Compensation vs Market: Clayton's total compensation ($USD472.59K) is above average for companies of similar size in the Australian market ($USD242.11K).
Compensation vs Earnings: Clayton's compensation has been consistent with company performance over the past year.
|CEO & Executive Director||4.67yrs||AU$770.51k||0.64% A$100.3k|
|Independent Non-Executive Director||4.42yrs||AU$70.00k||0.11% A$17.9k|
|Independent Non-Executive Director||1.5yrs||AU$58.33k||0.34% A$53.7k|
|Independent Non-Executive Chairman||4.42yrs||AU$85.00k||0.10% A$15.9k|
Experienced Board: AZV's board of directors are considered experienced (4.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Azure Healthcare Limited's company bio, employee growth, exchange listings and data sources
- Name: Azure Healthcare Limited
- Ticker: AZV
- Exchange: ASX
- Founded: 2004
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: AU$15.630m
- Shares outstanding: 284.19m
- Website: https://azurehealthcare.com.au
Number of Employees
- Azure Healthcare Limited
- 1/31 Sabre Drive
- Port Melbourne
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|AZVNA||ASX (Australian Securities Exchange)||NPV DFD 20/12/19(EX-RIGHTS)||AU||AUD||No data|
|AZV||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Sep 2004|
|AZV||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Sep 2004|
Azure Healthcare Limited, together with its subsidiaries, manufactures, services, supplies, and distributes healthcare and electronic communications equipment in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP based nurse call system for hospitals and aged care facilities. It also develops software. The company was formerly known as TSV Holdings Limited and changed its name to Azure Healthcare Limited in January 2012. Azure Healthcare Limited was incorporated in 2004 and is headquartered in Port Melbourne, Australia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/28 10:33|
|End of Day Share Price||2020/03/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.